Organic fluorescent nanoparticles with NIR-II emission for bioimaging and therapy

Biomed Mater. 2021 Feb 3;16(2):022001. doi: 10.1088/1748-605X/abca4a.

Abstract

Fluorescence imaging technology in the second near-infrared bio-channel (NIR-II) has the advantages of low light scattering and weak autofluorescence. It can obtain high spatial resolution imaging in deeper biological tissues and realize accurate diagnosis in the lesion. As a new cancer treatment method, photothermal therapy has the characteristics of obvious curative effect and small side effects. However, the hydrophobicity and non-selectivity of many fluorescent materials, aggregation-induced fluorescence quenching, and other problems lead to undesirable imaging results. Here, we reviewed the structure of the NIR-II fluorescent molecules and these dyes whose fluorescence tail emission is in the NIR-II bio-channel, discussed in detail how to realize the redshift of the dye wavelength, including modifying the push-pull electron system, extending the conjugated chain, and forming J-aggregates and other methods. We also summarize some strategies to improve brightness, including responsiveness, targeting, adjustment of aggregation mode, and aggregation-induced emission effect, thereby improving the imaging performance and therapeutic effect of NIR-II fluorescent dyes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Colorectal Neoplasms / drug therapy
  • Contrast Media / chemistry
  • Fluorescent Dyes / chemistry*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Liver / drug effects
  • Liver / metabolism
  • Microscopy, Fluorescence / methods*
  • Nanocomposites
  • Nanoparticles / chemistry*
  • Optical Imaging / methods
  • Photochemistry / methods
  • Polymers / chemistry
  • Reproducibility of Results
  • Signal Transduction

Substances

  • Contrast Media
  • Fluorescent Dyes
  • Polymers